Avinger Stock Rockets Higher After Receiving FDA Clearance for Next-Generation Pantheris

Posted in Medical Device

May 23, 2018 • 2 min read

Avinger (NASDAQ: AVGR) received welcome news today as they received received 510(k) clearance from the FDA for its next generation Pantheris® Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease. As we recently wrote, the success of the next generation Pantheris will play a crucial part in Avinger's turnaround plan. ...

PROCEPT Biorobotics presents positive Aquablation data at American Urological Association annual meeting

Posted in Medical Device

May 21, 2018 • 3 min read

Yesterday, during the American Urological Association Annual Meeting (AUA), PROCEPT Biorobotics announced early data from the global Phase III WATER II (Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue) Study showing the achievement of primary safety and efficacy endpoints for Aquablation in the treatment of benign prostatic hyperplasia (BPH). ​...

Surgeons are using Twitter to share ideas and improve surgical technique

Posted in Medical Device,

May 16, 2018 • 3 min read

Twitter has long been known as a great hangout for finance professionals. All day, users trade stock picks and pontificate on the state of world markets. Finding someone live tweeting CNBC isn't hard at all. It's also not hard to find a list of finance professionals to follow. What about healthcare? ...

Next Generation Pantheris imperative to Avinger's turnaround

Posted in Medical Device

May 15, 2018 • 5 min read

One year after their restructuring announcement, Avinger is slowly working their way through a turnaround that was expected to reduce net cash use to approximately $7 million per quarter by the third quarter of 2017, a reduction of 48% from the average quarterly cash use for 2016....